Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


23.07.2018

1 ACS Appl Mater Interfaces
3 Biomed Pharmacother
2 Biomed Res Int
1 BMC Cancer
1 Brachytherapy
1 Cancer Cell Int
1 Cell Death Dis
1 Cell Physiol Biochem
1 Curr Med Res Opin
1 Diagn Cytopathol
1 Eur J Cancer Prev
2 Eur Rev Med Pharmacol Sci
1 Glob Qual Nurs Res
1 Gynecol Oncol
2 Gynecol Oncol Rep
1 Infect Genet Evol
1 Int J Environ Res Public Health
2 Int J Gynaecol Obstet
1 Int J Health Sci (Qassim)
1 Int J Med Sci
1 Int J Mol Med
1 Int J Radiat Oncol Biol Phys
1 J Biochem
1 J Gynecol Oncol
1 J Health Psychol
2 Medicine (Baltimore)
1 Obstet Gynecol Sci
2 Oncol Lett
1 PLoS One
1 Radiat Oncol
1 RNA
1 Sci Rep
1 Strahlenther Onkol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    ACS Appl Mater Interfaces

  1. CHENG C, Meng Y, Zhang Z, Li Y, et al
    Tumoral Acidic pH-Responsive CDDP-Incorporated Cy5.5-PEG-g-A-HA Nanoparticles for Targeting Delivery of CDDP against Cervical Cancer.
    ACS Appl Mater Interfaces. 2018 Jul 19. doi: 10.1021/acsami.8b07425.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  2. KURIAKOSE GC, Lakshmanan M D, Bp A, Rs HK, et al
    Extract of Penicillium sclerotiorum an endophytic fungus isolated from Cassia fistula L. induces cell cycle arrest leading to apoptosis through mitochondrial membrane depolarization in human cervical cancer cells.
    Biomed Pharmacother. 2018;105:1062-1071.
    PubMed     Text format     Abstract available

  3. QIAN B, Zhao L, Wang X, Xu J, et al
    miR-149 regulates the proliferation and apoptosis of cervical cancer cells by targeting GIT1.
    Biomed Pharmacother. 2018;105:1106-1116.
    PubMed     Text format     Abstract available

  4. WU Y, Huang J, Xu H, Gong Z, et al
    Over-expression of miR-15a-3p enhances the radiosensitivity of cervical cancer by targeting tumor protein D52.
    Biomed Pharmacother. 2018;105:1325-1334.
    PubMed     Text format     Abstract available


    Biomed Res Int

  5. CHENG L, Guo Y, Zhan S, Xia P, et al
    Association between HLA-DP Gene Polymorphisms and Cervical Cancer Risk: A Meta-Analysis.
    Biomed Res Int. 2018;2018:7301595.
    PubMed     Text format     Abstract available

  6. LI W, Qi Y, Cui X, Huo Q, et al
    Characteristic of HPV Integration in the Genome and Transcriptome of Cervical Cancer Tissues.
    Biomed Res Int. 2018;2018:6242173.
    PubMed     Text format     Abstract available


    BMC Cancer

  7. GATUMO M, Gacheri S, Sayed AR, Scheibe A, et al
    Women's knowledge and attitudes related to cervical cancer and cervical cancer screening in Isiolo and Tharaka Nithi counties, Kenya: a cross-sectional study.
    BMC Cancer. 2018;18:745.
    PubMed     Text format     Abstract available


    Brachytherapy

  8. HARKENRIDER MM, Surucu M, Harmon G, Mysz ML, et al
    Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.
    Brachytherapy. 2018;17:187-193.
    PubMed     Text format     Abstract available


    Cancer Cell Int

  9. GAO J, Yu H, Guo W, Kong Y, et al
    The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells.
    Cancer Cell Int. 2018;18:102.
    PubMed     Text format     Abstract available


    Cell Death Dis

  10. DANG E, Yang S, Song C, Jiang D, et al
    BAP31, a newly defined cancer/testis antigen, regulates proliferation, migration, and invasion to promote cervical cancer progression.
    Cell Death Dis. 2018;9:791.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  11. LIU J, Wang D, Long Z, Liu J, et al
    CircRNA8924 Promotes Cervical Cancer Cell Proliferation, Migration and Invasion by Competitively Binding to MiR-518d-5p /519-5p Family and Modulating the Expression of CBX8.
    Cell Physiol Biochem. 2018;48:173-184.
    PubMed     Text format     Abstract available


    Curr Med Res Opin

  12. JONSKA-GMYREK J, Gmyrek L, Zolciak-Siwinska A, Kowalska M, et al
    Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer.
    Curr Med Res Opin. 2018 Jul 18:1-19. doi: 10.1080/03007995.2018.1502166.
    PubMed     Text format     Abstract available


    Diagn Cytopathol

  13. SAHIN D, Hacisalihoglu UP, Kirimlioglu SH
    Telecytology: Is it possible with smartphone images?
    Diagn Cytopathol. 2018;46:40-46.
    PubMed     Text format     Abstract available


    Eur J Cancer Prev

  14. BRANDAO M, Tulsidas S, Damasceno A, Silva-Matos C, et al
    Cervical cancer screening uptake in women aged between 15 and 64 years in Mozambique.
    Eur J Cancer Prev. 2018 Jul 16. doi: 10.1097/CEJ.0000000000000459.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  15. LI WT, Wang BL, Yang CS, Lang BC, et al
    MiR-613 promotes cell proliferation and invasion in cervical cancer via targeting PTPN9.
    Eur Rev Med Pharmacol Sci. 2018;22:4107-4114.
    PubMed     Text format     Abstract available

  16. HUANG LL, Rao W
    SiRNA interfering STAT3 enhances DDP sensitivity in cervical cancer cells.
    Eur Rev Med Pharmacol Sci. 2018;22:4098-4106.
    PubMed     Text format     Abstract available


    Glob Qual Nurs Res

  17. WOOD B, Russell VL, El-Khatib Z, McFaul S, et al
    "They Should Be Asking Us": A Qualitative Decisional Needs Assessment for Women Considering Cervical Cancer Screening.
    Glob Qual Nurs Res. 2018;5:2333393618783632.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  18. TIWARI R, Narayanan GS, Jayakumar V, Narayanan S, et al
    The promise of image-guided brachytherapy of better clinical outcomes in treatment of cervical cancer: Does it deliver? An Indian scenario.
    Gynecol Oncol. 2018 Jul 14. pii: S0090-8258(18)31068.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  19. AGER BJ, Gallardo-Rincon D, de Leon DC, Chavez-Blanco A, et al
    Advancing clinical research globally: Cervical cancer research network from Mexico.
    Gynecol Oncol Rep. 2018;25:90-93.
    PubMed     Text format     Abstract available

  20. YOST S, Hoekstra A
    Cervical cancer in women over 65: An analysis of screening.
    Gynecol Oncol Rep. 2018;25:48-51.
    PubMed     Text format     Abstract available


    Infect Genet Evol

  21. DAI S, Yao Y, Yan Z, Zhou Z, et al
    The association of human papillomavirus type 16 E2 variations with cervical cancer in a Han Chinese population.
    Infect Genet Evol. 2018;64:241-248.
    PubMed     Text format     Abstract available


    Int J Environ Res Public Health

  22. HAN J, Jungsuwadee P, Abraham O, Ko D, et al
    Shared Decision-Making and Women's Adherence to Breast and Cervical Cancer Screenings.
    Int J Environ Res Public Health. 2018;15.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  23. HERACLIO SA, de Souza ASR, de Souza PRE, Katz L, et al
    Cross-sectional study of anal intraepithelial lesions in women with cervical neoplasia without HIV.
    Int J Gynaecol Obstet. 2018;140:233-240.
    PubMed     Text format     Abstract available

  24. HAKEM E, Ibrahim E, Tanyous E, Astbury K, et al
    Association between grade of referral smear and high-grade disease among women with biopsy samples showing cervical intraepithelial neoplasia grade 2.
    Int J Gynaecol Obstet. 2018;140:223-227.
    PubMed     Text format     Abstract available


    Int J Health Sci (Qassim)

  25. SENG LM, Rosman AN, Khan A, Haris NM, et al
    Awareness of cervical cancer among women in Malaysia.
    Int J Health Sci (Qassim). 2018;12:42-48.
    PubMed     Text format     Abstract available


    Int J Med Sci

  26. LIN YH, Hsiao YH, Wu WJ, Yang SF, et al
    Relationship of genetic variant distributions of WW domain-containing oxidoreductase gene with uterine cervical cancer.
    Int J Med Sci. 2018;15:1005-1013.
    PubMed     Text format     Abstract available


    Int J Mol Med

  27. FAN L, Huang C, Li J, Gao T, et al
    Long noncoding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer.
    Int J Mol Med. 2018 Jul 13. doi: 10.3892/ijmm.2018.3778.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  28. DORTA-ESTREMERA S, Colbert LE, Mahalakshmi Krishna NS, Yanamandra AV, et al
    Kinetics of intratumoral immune cell activation during chemoradiation for cervical cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jul 12. pii: S0360-3016(18)31409.
    PubMed     Text format     Abstract available


    J Biochem

  29. TIMALSINA S, Arimoto-Matsuzaki K, Kitamura M, Xu X, et al
    Chemical compounds that suppress hypoxia-induced stress granule formation enhance cancer drug sensitivity of human cervical cancer HeLa cells.
    J Biochem. 2018 Jul 17. pii: 5055165. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  30. REN T, Suo J, Liu S, Wang S, et al
    Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer.
    J Gynecol Oncol. 2018 Jun 29. pii: 29.e78. doi: 10.3802/jgo.2018.
    PubMed     Text format     Abstract available


    J Health Psychol

  31. CRACIUN IC, Todorova I, Baban A
    "Taking responsibility for my health": Health system barriers and women's attitudes toward cervical cancer screening in Romania and Bulgaria.
    J Health Psychol. 2018 Jul 1:1359105318787616. doi: 10.1177/1359105318787616.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  32. YANG H, Zhang X, Hao Z
    The diagnostic accuracy of a real-time optoelectronic device in cervical cancer screening: A PRISMA-compliant systematic review and meta-analysis.
    Medicine (Baltimore). 2018;97:e11439.
    PubMed     Text format     Abstract available

  33. ZHANG Q, Liu A, Wu JJ, Niu M, et al
    Primary malignant mixed Mullerian tumors of the fallopian tube with cervix metastasis: A rare case report and literature review.
    Medicine (Baltimore). 2018;97:e11311.
    PubMed     Text format     Abstract available


    Obstet Gynecol Sci

  34. HEO YJ, Kim S, Min KJ, Lee S, et al
    The comparison of surgical outcomes and learning curves of radical hysterectomy by laparoscopy and robotic system for cervical cancer: an experience of a single surgeon.
    Obstet Gynecol Sci. 2018;61:468-476.
    PubMed     Text format     Abstract available


    Oncol Lett

  35. GE Y, Zhang C, Xiao S, Liang L, et al
    Identification of differentially expressed genes in cervical cancer by bioinformatics analysis.
    Oncol Lett. 2018;16:2549-2558.
    PubMed     Text format     Abstract available

  36. HU J, Meng Y, Zeng J, Zeng B, et al
    Ubiquitin E3 Ligase MARCH7 promotes proliferation and invasion of cervical cancer cells through VAV2-RAC1-CDC42 pathway.
    Oncol Lett. 2018;16:2312-2318.
    PubMed     Text format     Abstract available


    PLoS One

  37. KORI M, Yalcin Arga K
    Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective.
    PLoS One. 2018;13:e0200717.
    PubMed     Text format     Abstract available


    Radiat Oncol

  38. ROMANO KD, Hill C, Trifiletti DM, Peach MS, et al
    High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events.
    Radiat Oncol. 2018;13:129.
    PubMed     Text format     Abstract available


    RNA

  39. KURATA JS, Lin RJ
    MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs.
    RNA. 2018;24:966-981.
    PubMed     Text format     Abstract available


    Sci Rep

  40. LI J, Qi C, Liu X, Li C, et al
    Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo.
    Sci Rep. 2018;8:10594.
    PubMed     Text format     Abstract available


    Strahlenther Onkol

  41. STRNAD V
    Retrospective inconsistent analysis cannot validate safety of a treatment strategy.
    Strahlenther Onkol. 2018;194:354-355.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: